Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Use this GILD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the GILD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the GILD SEC filings page. Lician reads the product cache first so this HTML stays unique to Gilead Sciences Inc even when a live quote feed is slow.
Latest cached year on this hub. Full GILD income, balance, and cash tables.